Benzinga | May 13, 2021 04:25PM EDT

Histogen Q1 EPS $(0.14) Beats $(0.15) Estimate, Sales $431.00M Down From $978.00M YoY

Histogen (NASDAQ:HSTO) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. The company reported $431.00 million in sales this quarter. This is a 55.93 percent decrease over sales of $978.00 million the same period last year.